Transfusion‐transmissible coinfections among US blood donors
Transfusion · 2024
DOI: 10.1111/trf.18050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von Galen Conti und 9 weiteren Autor:innen. Beteiligte Einrichtung: American Red Cross, Rockville, Maryland, USA. Hauptthemen laut MEDLINE: Blood Donors, Coinfection, Syphilis, HIV Infections. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Food and Drug Administration, Office of the Assistant Secretary for Health, NIH HHS.
Abstract (Originalsprache)
Background
Transfusion‐transmissible infection (TTI) prevalence among US blood donors has been widely documented. Here we estimate the prevalence of donors presenting with ≥2 TTIs (multiple infections past or present referred to as coinfections) and describe their demographics and associations.
Methods
Data from the Transfusion‐Transmissible Infections Monitoring System were compiled for October 2020–September 2023 (3 years). Prevalence per million donations (pmd) was calculated for each TTI coinfection combination with demographic characteristics summarized. The odds of each TTI coinfection combination were estimated using logistic regression. Reactivity by NAT and/or serology (HIV, HBV, and HCV) defined donors as consensus positive (CP) for each infection while serology‐based algorithms defined syphilis CP and the subset with active syphilis infections (ASIs).
Results
About 22 million donations were included, with 212 coinfections (9.7 pmd). Around 2% of donations positive for any TTI ( n = 10,516) were coinfections. Coinfection prevalence per TTI combination ranged from 0.3 pmd for HIV CP and HCV CP, to 4.3 pmd for HIV CP and syphilis CP. There were high proportions of coinfections from donors who were male, aged 25–54 years, white or black, first time, and residing in the southern US Census Region. The odds of a second TTI occurring in an individual donor with a TTI ranged from 23 (95% CI: 13, 41) times more likely for HBV CP and ASI to 395 (95% CI: 298, 524) times more likely for HIV CP and ASI.
Conclusions
Coinfections are relatively uncommon among blood donors in the United States; however, associations exist among HIV, HBV, HCV, and syphilis infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- American Red Cross, Rockville, Maryland, USA.
- New York Blood Center Enterprises, New York, New York, USA.
- Vitalant Research Institute, San Francisco, California, USA.
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
- OneBlood, St. Petersburg, Florida, USA.
- US National Institutes of Health, Bethesda, Maryland, USA.
ORCID-Profile: Galen Conti, Brian Custer, Barbee I Whitaker, Susan L Stramer
Förderung
- U.S. Food and Drug Administration
- Office of the Assistant Secretary for Health
- NIH HHS
- National Institutes of Health
Zitieren
APA
Conti, G., Notari, E. P., Dodd, R. Y., Gorlin, J., Custer, B., Reik, R., Hailu, B., Whitaker, B. I., Stramer, S. L., & U.S. Transfusion‐Transmissible Infections Monitoring System (TTIMS) (2024). Transfusion‐transmissible coinfections among US blood donors. Transfusion. https://doi.org/10.1111/trf.18050
Vancouver
Conti G, Notari EP, Dodd RY, Gorlin J, Custer B, Reik R, et al. Transfusion‐transmissible coinfections among US blood donors. Transfusion. 2024. doi:10.1111/trf.18050
BibTeX
@article{Conti2024,
author = {Conti, Galen and Notari, Edward P and Dodd, Roger Y and Gorlin, Jed and Custer, Brian and Reik, Rita and Hailu, Benyam and Whitaker, Barbee I and Stramer, Susan L and U.S. Transfusion‐Transmissible Infections Monitoring System (TTIMS), U.S. Transfusion‐Transmissible Infections Monitoring System (TTIMS)},
title = {Transfusion‐transmissible coinfections among US blood donors},
journal = {Transfusion},
year = {2024},
doi = {10.1111/trf.18050}
}
EUVIMED